公司資料

HOOKIPA Pharma Inc. 股價、新聞與催化劑

股票代碼:: HOOK
交易所:: NASDAQ
產業:: Biopharma
所在地:: United States

股票表現

1.15 USD (+0.88%)

收盤價

最後更新: 2026年6月2日

—

市值

股價為何變動

Current closing-price context is not available for HOOK.

公司概覽

業務概覽

Hookipa Pharma is a biopharmaceutical company focused on immunotherapy and oncology, with a strategy that has centered on viral-vector and immune-based platforms. Its business has been shaped by platform ambition and strategic resets.

所在地與產業分類

Headquartered in the United States and listed on NASDAQ, Hookipa sits in specialty biotechnology.

商業模式特徵

The company depends on clinical validation, partnerships, and the ability to find a durable immune-therapy franchise.

生技產業定位

Hookipa is a high-risk immunology name whose story depends heavily on platform and financing progress.

未來催化劑

HOOKIPA’s catalysts are HB-700 and the rest of its viro-immunotherapy platform, plus any partnership or strategic update. The market will care about whether the viral-immunotherapy thesis still has a path.